Skin Channel
Related Channels

Istodax Uses

Istodax may be given to adults age 18 and older to treat certain types of T-cell lymphoma. It is specifically approved to help improve T-cell lymphoma and peripheral T-cell lymphoma. However, studies have not shown that using this drug will prolong survival. There are also occasions where a person might use Istodax for off-label (unapproved) purposes, such as to treat other forms of T-cell lymphoma.

What Is Istodax Used For?

Istodax® (romidepsin) is a prescription medication approved for the treatment of certain types of T-cell lymphoma (cancer of the white blood cells, or lymphocytes). Specifically, it is approved to treat people with cutaneous T-cell lymphoma (CTCL) who have already been treated with at least one other medication given by mouth or injection. It is also approved to treat people with peripheral T-cell lymphoma who have already received at least one other treatment.

What Is Lymphoma?

Lymphoma is a type of cancer that begins in the cells of the immune system. It occurs when cells in the lymphatic system become abnormal. The abnormal cells divide too rapidly and grow without any order or control. Because lymphatic tissue is present in many parts of the body, lymphoma can start almost anywhere, such as:
  • A single lymph node
  • A group of lymph nodes
  • Other parts of the lymphatic system, such as the bone marrow or spleen.
There are many possible symptoms of lymphoma. Some of these symptoms may include but are not limited to:
  • Swollen, painless lymph nodes in the neck, armpits, or groin
  • Unexplained weight loss
  • Night sweats
  • Fever
  • Coughing, trouble breathing, or chest pain
  • Weakness or tiredness
  • Patches of itchy skin or a rash.
There are two basic categories of lymphoma. One type is Hodgkin's lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other type is non-Hodgkin's lymphoma, which includes a large, diverse group of cancers of immune system cells.
Non-Hodgkin's lymphoma can be categorized by the type of immune cell affected, which can include T-cells, B-cells, and natural killer cells. Non-Hodgkin's lymphoma can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course.
Peripheral T-cell lymphoma and cutaneous T-cell lymphoma are just two of several types of T-cell lymphoma. There is also a wide variety of peripheral and cutaneous T-cell lymphomas. For example, mycosis fungoides and Sézary syndrome are two types of cutaneous T-cell lymphoma. In general, cutaneous T-cell lymphoma is an indolent lymphoma that starts in the T-cells in the skin, while peripheral T-cell lymphoma is a more aggressive form.
Istodax has been shown to improve cutaneous T-cell lymphoma and peripheral T-cell lymphoma in people with these conditions. For example, there may be less involvement of the skin or lymph nodes while taking the medicine. However, studies have not yet demonstrated that the medicine prolongs survival.
5 Easy Tips to Manage Visitors During Cancer Treatment

Istodax Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2018 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.